Kenneth Blum

Also affiliated with University of Vermont, Centre for Addiction and Mental Health, Wright State University, Center for Personalized Cancer Treatment, Assheuer + Pott (Germany), Texas Research Institute, Institute of Bioinformatics and Applied Biotechnology, UCSF Helen Diller Family Comprehensive Cancer Center, Ariel University, Case Western Reserve University, Western University of Health Sciences, Stanford University

NeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 44 papers. Top paper: “Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction”.

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction

Journal of Reward Deficiency Syndrome(2015)10.17756/jrds.2015-016

N/A

0.713DataRank · unranked

115 citations

Peter Thanos, Marlene Oscar-Berman, Kenneth Blum

Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions

International Journal of Environmental Research and Public Health(2021)10.3390/ijerph182111529

N/A

0.520DataRank · unranked

31 citations

Abdalla Bowirrat, Eric R. Braverman, David Baron, Jean Lud Cadet, Shan Kazmi +8 more

Why haven't we solved the addiction crisis?

Journal of the Neurological Sciences(2022)10.1016/j.jns.2022.120404

N/A

0.434DataRank · unranked

17 citations

Abdalla Bowirrat, Luis Llanos Gomez, B. William Downs, Debasis Bagchi, Debmalya Barh +12 more

The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research

Journal of Personalized Medicine(2023)10.3390/jpm13071164

N/A

0.425DataRank · unranked

16 citations

Colin Hanna, Abrianna Mihalkovic, Aaron B. Hoffman, Alan Posner, John Busch +7 more

Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

International Journal of Environmental Research and Public Health(2022)10.3390/ijerph19116395

N/A

0.396DataRank · unranked

13 citations

Ashim Gupta, Abdalla Bowirrat, David Baron, Rajendra D. Badgaiyan, Igor Elman +5 more

Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography

Journal of Addiction Psychiatry(2024)10.17756/jap.2024-043

N/A

0.360DataRank · unranked

10 citations

David Baron, Thomas McLaughlin, Panayotis K Thanos, Catherine A. Dennen, Mauro Ceccanti +6 more

“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation

Annals of Translational Medicine(2022)10.21037/atm-2022-32

N/A

0.330DataRank · unranked

8 citations

Igor Elman, Catherine A. Dennen, Thomas McLaughlin, Panayotis K. Thanos, David Baron +3 more

Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk

Substance Abuse and Rehabilitation(2025)10.2147/sar.s514931

N/A

0.241DataRank · unranked

4 citations

Kenneth Blum, Kai‐Uwe Lewandrowski, Mark S. Gold, Alexander P. L. Lewandrowski, Panayotis K. Thanos +7 more

Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy

Journal of Addiction Psychiatry(2024)10.17756/jap.2024-045

N/A

0.208DataRank · unranked

3 citations

Nicole Jafari, David Baron, Abdalla Bowirrat, Albert Pinhasov, Brian Norling +37 more

Invited Expert Opinion- Bio-informatic and Limitation Di-rectives to Help Adopt Ge-netic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Re-quired Analytic Evidence to Induce Dopamine Homeo-statsis

Medical Research Archives(2023)10.18103/mra.v11i8.4211

N/A

0.208DataRank · unranked

3 citations

Mark S. Gold, Jean Lud Cadet, Marjorie Lewis, Thomas McLaughlin, Eric R. Braverman +20 more

Are We Getting High Cause the Thrill is Gone?

Journal of Addiction Psychiatry(2023)10.17756/jap.2023-041

N/A

0.104DataRank · unranked

1 citations

Thomas McLaughlin, Mark S. Gold, Marjorie C. Gondré‐Lewis, Panayotis K. Thanos, Igor Elman +15 more

Psychostimulants for Children: Are We Over or Under Dosing?

Journal of Addiction Psychiatry(2023)10.17756/jap.2023-040

N/A

0.104DataRank · unranked

1 citations

Catherine A. Dennen, Paul R. Carney, Elizabeth Gilley, Panayotis K. Thanos, Eric R. Braverman +7 more

Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?

Journal of Personalized Medicine(2022)10.3390/jpm12020321

N/A

0DataRank · unranked

43 citations

Thomas McLaughlin, Abdalla Bowirrat, Edward J. Modestino, David Baron, Luis Llanos Gomez +12 more

Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?

Biomedicines(2022)10.3390/biomedicines10040870

N/A

0DataRank · unranked

20 citations

Igor Elman, Tanya N. Alim, Edwin Chapman, Beverlyn Settles-Reaves, Carine Galvao +8 more

Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of “Dopamine Homeostasis”

Open Journal of Immunology(2022)10.4236/oji.2022.123004

N/A

0DataRank · unranked

4 citations

Catherine A. Dennen, Eric R. Braverman, Ashim Gupta, David Baron, Bernard W. Downs +8 more

Offering a putative neurobiological “dopamine homeostatic” solution to overcome the perils of the reward deficiency syndrome pandemic: emergence of “precision behavioral management”

Annals of Translational Medicine(2022)10.21037/atm-2022-67

N/A

0DataRank · unranked

3 citations

Catherine A. Dennen, David Baron, Panayotis K. Thanos, Rajendra D. Badgaiyan, Kenneth Blum

Fatty Acid-Binding Protein 5 Gene Deletion Enhances Nicotine-Conditioned Place Preference: Illuminating the Putative Gateway Mechanisms

Future Pharmacology(2023)10.3390/futurepharmacol3010007

N/A

0DataRank · unranked

12 citations

Brittany Richardson, Abrianna Mihalkovic, Samantha Penman, Olivia White, John Hamilton +5 more

Genetic Correlates as a Predictor of Bariatric Surgery Outcomes after 1 Year

Biomedicines(2023)10.3390/biomedicines11102644

N/A

0DataRank · unranked

11 citations

Colin Hanna, Abrianna Mihalkovic, Aaron B. Hoffman, Alan Posner, John L. Butsch +5 more

Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry

Journal of the Neurological Sciences(2023)10.1016/j.jns.2023.120809

N/A

0DataRank · unranked

10 citations

J. Wesson Ashford, Babak Kateb, Daniel Sipple, Eric R. Braverman, Catherine A. Dennen +14 more

Vaporized Delta-9-tetrahydrocannabinol Inhalation in Female Sprague DawleyRats: A Pharmacokinetic and Behavioral Assessment

Current Pharmaceutical Design(2023)10.2174/1381612829666230419093809

N/A

0DataRank · unranked

10 citations

Erin C. Berthold, Abrianna Mihalkovic, Nikki Hammond, Christopher R. McCurdy, Kenneth Blum +4 more

Reward Deficiency Syndrome Solution System (RDSSS) A Genetically Driven Putative Inducer of “Dopamine Homeostasis” as a Futuristic Alternative to Enhance Rehabilitation Instead of Incarceration

Asian Journal of Complementary and Alternative Medicine(2023)10.53043/2347-3894.acam11003

N/A

0DataRank · unranked

2 citations

Richard Green, Paul Mullen, David K. Han, Abdalla Bowirrat, Igor Elman +6 more

Futuristic Exploration of Addiction Neuroscience in the Genomic Era

Psychology Research and Behavior Management(2023)10.2147/prbm.s439837

N/A

0DataRank · unranked

0 citations

Igor Elman, Abdalla Bowirrat, David Baron, Panayotis K. Thanos, Colin Hanna +3 more

A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy

Cellular and Molecular Neurobiology(2024)10.1007/s10571-024-01466-5

N/A

0DataRank · unranked

11 citations

Alireza Sharafshah, John C. Elfar, Sergio L. Schmidt, Kenneth Blum, F. Todd Wetzel +1 more

Addictive Behavior and Evolutionary Adaptation: Mitigated through Genetic Addiction Risk Severity Early Identification and Awareness Integration Theory

Medical Research Archives(2024)10.18103/mra.v12i8.5702

N/A

0DataRank · unranked

1 citations

Nicole Jafari, Eileen Manoukian, Kenneth Blum, Foojan Zeine

The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies

Open Journal of Immunology(2024)10.4236/oji.2024.143006

N/A

0DataRank · unranked

2 citations

Igor Elman, David Han, Colin Hanna, David Baron, Ashim Gupta +21 more

Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty Cases

Journal of Addiction Psychiatry(2024)10.17756/jap.2024-046

N/A

0DataRank · unranked

0 citations

Thomas McLaughlin, Kai‐Uwe Lewandrowski, Alireza Sharafshah, Catherine A. Dennen, Panayotis K. Thanos +10 more

Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia

Frontiers in Public Health(2025)10.3389/fpubh.2025.1594872

N/A

0DataRank · unranked

1 citations

Kenneth Blum, Alexander P. L. Lewandrowski, Panayotis K. Thanos, Albert Pinhasov, Alireza Sharafshah +19 more

Pre-clinical models of reward deficiency syndrome: A behavioral octopus

Neuroscience & Biobehavioral Reviews(2020)10.1016/j.neubiorev.2020.04.021

N/A

0DataRank · unranked

43 citations

Rosemary B. Bassey, Kenneth Blum, Marjorie C. Gondré‐Lewis

Addiction Risk Polymorphisms Links Autism Spectrum Disorder with Reward Deficiency Syndrome: Insights from GWAS and Pharmacogenomic Meta Analyses

Preprints.org(2025)10.20944/preprints202507.0381.v1

N/A

0DataRank · unranked

0 citations

Kenneth Blum, Kavya Mohankumar, Milan Makale, Abdalla Bowirrat, Albert Pinhasov +23 more

GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents

Preprints.org(2025)10.20944/preprints202510.1849.v1

N/A

0DataRank · unranked

0 citations

Shaurya Mahajan, Alireza Sharafshah, Keerthy Sunder, Kai‐Uwe Lewandrowski, Kavya Mohankumar +22 more

Billions Spent, Few Saved: Rethinking National Institutes of Health HEAL Initiative in Light of Dopaminergic Alternatives to the Opioid Trap

The International Journal of Spine Surgery(2025)10.14444/8804

N/A

0DataRank · unranked

0 citations

Kenneth Blum, Morgan P. Lorio, Sergio L. Schmidt, Rossano Kepler Alvim Fiorelli, Kai‐Uwe Lewandrowski

Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis Medicinals

Research Square(2025)10.21203/rs.3.rs-8140327/v1

N/A

0DataRank · unranked

0 citations

Alireza Sharafshah, Jag Khalsa, Kai-Uwe Lewandrowski, Panayotis K. Thanos, Marco Lindenau +33 more

Theorizing The Role of Gama Type Endorphins in Schizophrenia and Alcoholism: Promoting Genetic Testing and Attempts at Inducing “Dopamine Homeostasis”

Acta Scientific Neurology(2025)10.31080/asne.2025.08.0817

N/A

0DataRank · unranked

0 citations

Kai Uwe Lewandowski, Alireza Sharafshah, Catherine A. Dennen, Albert Pinhasov, Abdalla Bowirrat +7 more

Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS)

Journal of the Neurological Sciences(2020)10.1016/j.jns.2020.116733

N/A

0DataRank · unranked

35 citations

David Baron, Thomas McLaughlin, Mark S. Gold, Kenneth Blum

Administration of a putative pro-dopamine regulator, a neuronutrient, mitigates alcohol intake in alcohol-preferring rats

Behavioural Brain Research(2020)10.1016/j.bbr.2020.112563

N/A

0DataRank · unranked

29 citations

Tomilowo Abijo, Carine Galvao, Philippe J. Darius, Kenneth Blum, Marjorie C. Gondré‐Lewis +1 more

Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia

Current Psychopharmacologye(2020)10.2174/2211556009999200628093231

N/A

0DataRank · unranked

2 citations

Kenneth Blum, Abdalla Bowirrat, Edward J. Modestino, David Baron, Rajendra D. Badgaiyan +4 more

High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial

Molecular Neurobiology(2021)10.1007/s12035-021-02312-1

N/A

0DataRank · unranked

40 citations

Kenneth Blum, Jessica V. Ponce, Lisa Lott, Marjorie C. Gondré‐Lewis, Sampada Badgaiyan +13 more

Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis

Frontiers in Psychiatry(2021)10.3389/fpsyt.2021.623403

N/A

0DataRank · unranked

33 citations

Jag Khalsa, Jean Lud Cadet, David Baron, Abdalla Bowirrat, Brent Boyett +7 more

Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) during Adolescent Brain Development

Current Psychopharmacologye(2021)10.2174/2211556010666210215155509

N/A

0DataRank · unranked

28 citations

Abdalla Bowirrat, Marjorie C. Gondre -Lewis, Thomas Simpatico, Mauro Ceccanti, Bruce Steinberg +10 more

Dopaminylation in Psychostimulant Use Disorder Protects Against PsychostimulantSeeking Behavior by Normalizing Nucleus Accumbens (NAc)Dopamine Expression

Current Psychopharmacologye(2021)10.2174/2211556009666210108112737

N/A

0DataRank · unranked

15 citations

Mark S. Gold, Jean Lud Cadet, David Baron, Abdalla Bowirrat, Panayotis K. Thanos +4 more

Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic

Current Psychopharmacologye(2021)10.2174/2211556009999210104221215

N/A

0DataRank · unranked

13 citations

Edward J. Modestino, David Baron, Raymond Brewer, Panayotis K. Thanos, Igor Elman +8 more

A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”

Psychology Research and Behavior Management(2021)10.2147/prbm.s292958

N/A

0DataRank · unranked

12 citations

Bruce Steinberg, Marjorie C Gondré-Lewis, David Baron, Edward J. Modestino, Rajendra D. Badgaiyan +7 more

Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling

Current Psychopharmacologye(2021)10.2174/2211556010666210215153513

N/A

0DataRank · unranked

9 citations

Thomas McLaughlin, Edward J. Modestino, David Baron, Abdalla Bowirrat, Raymond Brewer +6 more

Review: Cannabinoids as Medicinals

Current Addiction Reports(2022)10.1007/s40429-022-00438-3

N/A

0DataRank · unranked

61 citations

Gregory Bunt, Kenneth Blum, Sanjay B. Maggirwar, Marc Galanter, Marc N. Potenza +1 more